384 related articles for article (PubMed ID: 15580801)
1. Successful implementation of perinatal HIV prevention guidelines. A multistate surveillance evaluation.
Wortley PM; Lindegren ML; Fleming PL
MMWR Recomm Rep; 2001 May; 50(RR-6):17-28. PubMed ID: 15580801
[TBL] [Abstract][Full Text] [Related]
2. HIV infection and zidovudine use in childbearing women.
Sia J; Paul S; Martin RM; Cross H
Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
[TBL] [Abstract][Full Text] [Related]
3. Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996-2000, pediatric spectrum of HIV disease cohort.
Peters V; Liu KL; Dominguez K; Frederick T; Melville S; Hsu HW; Ortiz I; Rakusan T; Gill B; Thomas P
Pediatrics; 2003 May; 111(5 Pt 2):1186-91. PubMed ID: 12728136
[TBL] [Abstract][Full Text] [Related]
4. Update: perinatally acquired HIV/AIDS--United States, 1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1997 Nov; 46(46):1086-92. PubMed ID: 9385878
[TBL] [Abstract][Full Text] [Related]
5. Success in implementing Public Health Service guidelines to reduce perinatal transmission of HIV--Louisiana, Michigan, New Jersey, and South Carolina, 1993, 1995, and 1996.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1998 Aug; 47(33):688-91. PubMed ID: 9733415
[TBL] [Abstract][Full Text] [Related]
6. From the Centers for Disease Control and Prevention. Progress toward elimination of perinatal HIV infection--Michigan, 1993-2000.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2002 Feb; 51(5):93-7. PubMed ID: 11892955
[TBL] [Abstract][Full Text] [Related]
7. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial.
Taha TE; Kumwenda NI; Hoover DR; Fiscus SA; Kafulafula G; Nkhoma C; Nour S; Chen S; Liomba G; Miotti PG; Broadhead RL
JAMA; 2004 Jul; 292(2):202-9. PubMed ID: 15249569
[TBL] [Abstract][Full Text] [Related]
8. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
Mofenson LM;
MMWR Recomm Rep; 2002 Nov; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844
[TBL] [Abstract][Full Text] [Related]
9. Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?
Briand N; Warszawski J; Mandelbrot L; Dollfus C; Pannier E; Cravello L; Nguyen R; Matheron I; Winer N; Tubiana R; Rouzioux C; Faye A; Blanche S;
Clin Infect Dis; 2013 Sep; 57(6):903-14. PubMed ID: 23728147
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with zidovudine receipt and prenatal care among HIV-infected pregnant women in New Jersey.
Abatemarco DJ; Catov JM; Cross H; Delnevo C; Hausman A
J Health Care Poor Underserved; 2008 Aug; 19(3):814-28. PubMed ID: 18677072
[TBL] [Abstract][Full Text] [Related]
11. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention.
MMWR Recomm Rep; 1998 Jan; 47(RR-2):1-30. PubMed ID: 9461044
[TBL] [Abstract][Full Text] [Related]
12. Prenatal HIV testing and antiretroviral prophylaxis at an urban hospital--Atlanta, Georgia, 1997-2000.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Jan; 52(51-52):1245-8. PubMed ID: 14704648
[TBL] [Abstract][Full Text] [Related]
13. [Estimate of HIV-1 infection prevalence in pregnant women and effectiveness of zidovudine administered during pregnancy in the prevention of vertical transmission].
Ramos Amador JT; Contreras JR; Bastero R; Barrio C; Moreno P; Delgado R; Muñoz E; Jiménez J
Med Clin (Barc); 2000 Mar; 114(8):286-91. PubMed ID: 10774515
[TBL] [Abstract][Full Text] [Related]
14. The use of short-course zidovudine to prevent perinatal transmission of human immunodeficiency virus in rural Kenya.
Songok EM; Fujiyama Y; Tukei PM; Vulule JM; Kiptoo MK; Adungo NO; Kakimoto K; Kobayashi N; Genga IO; Mpoke S; Ichimura H
Am J Trop Med Hyg; 2003 Jul; 69(1):8-13. PubMed ID: 12932089
[TBL] [Abstract][Full Text] [Related]
15. Reduction in perinatal transmission and mortality from human immunodeficiency virus after intervention with zidovudine in Barbados.
St John AM; Kumar A; Cave C
Pediatr Infect Dis J; 2003 May; 22(5):422-6. PubMed ID: 12792382
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of intensive nurse case management in decreasing vertical transmission of human immunodeficiency virus infection in Wisconsin.
Havens PL; Cuene BE; Hand JR; Gern JE; Sullivan BW; Chusid MJ
Pediatr Infect Dis J; 1997 Sep; 16(9):871-5. PubMed ID: 9306482
[TBL] [Abstract][Full Text] [Related]
17. Trends in perinatal transmission of HIV/AIDS in the United States.
Lindegren ML; Byers RH; Thomas P; Davis SF; Caldwell B; Rogers M; Gwinn M; Ward JW; Fleming PL
JAMA; 1999 Aug; 282(6):531-8. PubMed ID: 10450714
[TBL] [Abstract][Full Text] [Related]
18. The impact of zidovudine use in HIV-infected pregnant women on vertical transmission of HIV in Mississippi.
Palmer AL; Gay H; Currier MM
J Miss State Med Assoc; 2000 Feb; 41(2):479-83. PubMed ID: 10710894
[TBL] [Abstract][Full Text] [Related]
19. Intrapartum and neonatal zidovudine treatment in reduction of perinatal HIV-1 transmission in Bangkok.
Thaithumyanon P; Thisyakorn U; Limpongsanurak S; Chaithongwongwatthana S; Punnahitanon S; Ubolyam S; Phanuphak P; Ruxrungtham K; Virutamasen P
J Med Assoc Thai; 2001 Sep; 84(9):1229-34. PubMed ID: 11800293
[TBL] [Abstract][Full Text] [Related]
20. Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties.
Fiscus SA; Adimora AA; Schoenbach VJ; Lim W; McKinney R; Rupar D; Kenny J; Woods C; Wilfert C
JAMA; 1996 May; 275(19):1483-8. PubMed ID: 8622222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
